April 7, 2021 08:56 AM EDTUpdated 11:27 AM

Covid-19 roundup: AstraZeneca pauses vaccine trial for children as blood clot probe continues; EMA to investigate whether Sputnik V trials met GCP standards — report

Amber Tong

Nicole DeFeudis

Editor

Josh Sullivan

AstraZeneca and partners at Oxford University have halted dosing of their Covid-19 vaccine to children in a small clinical trial in the latest hiccup caused …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: AstraZeneca pauses vaccine trial for children as blood clot probe continues; EMA to investigate whether Sputnik V trials met GCP standards — report

Amber Tong

Nicole DeFeudis

Editor

Josh Sullivan

Sign up to read this article for free.

Pfizer looking to sell hospital drugs unit — reports

'Expertise is a real thing': FDA commissioner warns of political risk to agency

AstraZeneca CEO reaffirms commitment to China following executive's detention

Merck, AstraZeneca tout Phase 3 win for cancer-turned-rare disease drug

Sanofi, OpenAI, Formation Bio debut patient recruiting tool, will use in Phase 3 multiple sclerosis studies

What Will It Take to Reverse Fibrosis in Patients with Advanced MASH?

Covid-19 roundup: As­traZeneca paus­es vac­cine tri­al for chil­dren as blood clot probe con­tin­ues; EMA to in­ves­ti­gate whether Sput­nik V tri­als met GCP stan­dards — re­port

Editor

Sign up to read this article for free.

Covid-19 roundup: AstraZeneca pauses vaccine trial for children as blood clot probe continues; EMA to investigate whether Sputnik V trials met GCP standards — report